We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 55

HHS Proposes Disclosure of Drug Prices in TV Advertising, But Fight Over Authority On the Horizon
  • Arent Fox LLP
  • USA
  • October 29 2018

The Department of Health and Human Services (HHS) has issued a proposed rule (PR) which would require any television advertisement for a drug or


FDA Targets Sales of E-Cigarette Manufacturer Juul to Minors in Surprise Inspection
  • Arent Fox LLP
  • USA
  • October 8 2018

According to reports, two FDA inspectors, at times joined by a third official, arrived the morning of September 24 to Juul’s San Francisco office and


FDA is Getting Ready for Its Close-up on Labels
  • Arent Fox LLP
  • USA
  • August 24 2018

Through a series of recent statements, FDA Commissioner Scott Gottlieb has signaled that the agency is prepared to assert its enforcement authority


APHIS Changes Import Permit Policy for Medical Devices Containing Animal Derived Ingredients
  • Arent Fox LLP
  • USA
  • June 13 2018

Medical devices containing animal derived ingredients that have been approved by the Food and Drug Administration now may enter the US without the


In Rare Move, FDA Debars Company from Importing Food
  • Arent Fox LLP
  • USA
  • March 15 2018

For the first time in recent history, the Food and Drug Administration has debarred a foreign firm from importing food into the United States. The


FDA Authorizes First Direct-to-Consumer Genetic Test for Cancer
  • Arent Fox LLP
  • USA
  • March 14 2018

On March 6, 2018, the US Food and Drug Administration issued an authorization letter to 23andMe, Inc. that permits marketing of the company’s genetic


FDA Taps the Brakes on Certain Aspects of FSMA Compliance
  • Arent Fox LLP
  • USA
  • January 17 2018

Recently, the FDA announced that it does not intend to enforce certain provisions in four of the rules that implement the FDA Food Safety


FDA Trip Leads to Securities Stumble: The Gravity of Regulatory Due Diligence
  • Arent Fox LLP
  • USA
  • September 7 2017

After three years of litigation, a medical device manufacturer has agreed to pay $7 million to settle a class action lawsuit that claimed the company


Consumer Groups File False Advertising Suit Over ‘100 Natural’ Claim, Alleging Residues in Poultry
  • Arent Fox LLP
  • USA
  • July 5 2017

Continuing a trend that is certain to keep growing, three consumer groups recently filed a lawsuit against Sanderson Farms alleging false advertising


FDA Extends Compliance Date for Nutritional Facts Panel Revision
  • Arent Fox LLP
  • USA
  • June 15 2017

In a widely anticipated move, the FDA announced this week that it will extend the July 2018 compliance date for the revision to the Nutrition Facts